Park Jae-won is the CEO of DongKook Life Science.
He is accelerating the expansion of the company’s distribution business portfolio, including medical devices, while focusing on increasing production capacity in the existing contrast agent business.
He was born on March 5, 1965.
He graduated from Kyung Hee University College of Pharmacy and earned his master’s degree from the same university’s graduate school.
He previously worked at the German pharmaceutical company Bayer as an executive overseeing marketing for the Asia region and as CEO of the R&I business division, before joining DongKook Pharmaceutical as a marketing executive in the contrast agent division.
After DongKook Life Science was spun off, he served as head of the New Business Division and was appointed CEO in 2022.
He is recognized as a marketing expert in the pharmaceutical and biotechnology sectors.
He is goal-oriented and known for his strong drive.
He shows a strong commitment to global market expansion and new business development.
#ParkJaeWon #DongKookLifeScience #pharmaceuticals #biotechnology #marketing #leadership #Bayer #KyungHeeUniversity #contrastagent #globalexpansion